发明名称 ABUSE-RESISTANT ORAL DOSAGE FORMS AND METHOD OF USE THEREOF
摘要 An opioid-antagonist oral dosage form which does not release a therapeutically effective amount of the opioid antagonist when the oral dosage form is orally administered to a human being, but whereby a physical alteration of the oral dosage form results in a release of the therapeutically effective amount of the opioid antagonist. An embodiment of the oral dosage form includes an opioid-antagonist layer coated onto a biologically inert pellet, and a non-releasing membrane coated onto the opioid-antagonist layer. Optionally, the oral dosage form can also include an opioid agonist, such that a method of preventing the abuse of an oral dosage form of an opioid agonist is provided by forming the oral dosage form including an opioid agonist and an opioid antagonist.
申请公布号 EP1615623(A4) 申请公布日期 2012.02.22
申请号 EP20040759447 申请日期 2004.04.08
申请人 ELITE LABORATORIES, INC. 发明人 MEHTA, ATUL M.
分类号 A61K9/14;A61K;A61K9/16;A61K9/22;A61K9/24;A61K9/48;A61K9/50;A61K9/52;A61K9/54;A61K9/58;A61K9/60;A61K9/62;A61K9/64;A61K31/485 主分类号 A61K9/14
代理机构 代理人
主权项
地址